Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation

Molecular and Cellular Biology

Volumn 24, Issue 6, 2004, Pages 2251-2262

  Kim, Byung Chul ^a,b   Lee, Ho Jae ^a   Park, Seok Hee ^c   Lee, Sae Ra ^a   Karpova, Tatiana S ^a   McNally, James G ^a   Felici, Angelina ^a   Lee, Dug Keun ^a   Kim, Seong Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Kangwon National University   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PROTEIN CSN5; PROTEIN JAB1; SMAD7 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; COS CELLS; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PEPTIDE HYDROLASES; PROTEIN BINDING; PROTEINS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA;

EID: 1542314268     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.6.2251-2262.2004     Document Type: Article

References (59)

1. Afrakhte, M., A. Moren, S. Jossan, S. Itoh, K. Sampath, B. Westermark, C.-H. Heldin, N. E. Heldin, and P. ten Dijke. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun. 249:505-511.
2. Attisano, L., and J. L. Wrana. 2000. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12:235-243.
3. Bae, M. K., M. Y. Ahn, J. W. Jeong, M. H. Bae, Y. M. Lee, S. K. Bae, J. W. Park, K. R. Kim, and K. W. Kim. 2002. Jab1 interacts directly with HIF-1α and regulates its stability. J. Biol. Chem. 277:9-12.
4. Bech-Otschir, D., M. Seeger, and W. Dubiel. 2002. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J. Cell Sci. 115:467-473.
5. Bianchi, E., S. Denti, A. Granata, G. Bossi, J. Geginat, A. Villa, L. Rogge, and R. Pardi. 2000. Integrin LFA-1 interacts with the transcriptional coactivator JAB1 to modulate AP-1 activity. Nature 404:617-621.
6. Bitzer, M., G. von Gersdorff, D. Liang, A. Dominguez-Rosales, A. A. Beg, M. Rojkind, and E. P. Böttinger. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NFκB/RelA. Genes Dev. 14:187-197.
7. Bonifacino, J. S., and A. M. Weissman. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Biol. 14:19-57.
8. Casellas, R., and A. H. Brivanlou. 1998. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev. Biol. 198:1-12.
9. Chauchereau, A., M. Georgiakaki, M. Perrin-Wolff, E. Milgrom, and H. Loosfelt. 2000. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 275:8540-8548.
10. Chen, H. I., and M. Sudol. 1995. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA 92:7819-7823.
11. Claret, F. X., M. Hibi, S. Dhut, T. Toda, and M. Karin. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453-457.
12. Dechend, R., F. Hirano, K. Lehman, V. Heissmeyer, S. Ansieau, F. G. Wulczyn, C. Scheidereit, and A. Leutz. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene 18:3316-3323.
13. Deng, X. W., W. Dubiel, N. Wei, K. Hofmann, and K. Mundt. 2000. Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet. 16:202-203.
14. Derynck, R., Y. Zhang, and X.-H. Feng. 1998. Smads: transcriptional activators of TGF-β responses. Cell 95:737-740.
15. Deshaies, R. J. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15:435-467.
16. Ebisawa, T., M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura, and K. Miyazono. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276:12477-12480.
17. Eppert, K., S. W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L. C. Tsui, B. Bapat, S. Gallinger, I. L. Andrulis, G. H. Thomsen, J. L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552.
18. Fujii, M., K. T. Takeda, H. Imamura, T. K. Aoki, S. Sampath, M. Enomoto, M. Kawabata, H. Kato, H. Ichijo, and K. Miyazono. 1999. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10:3801-3813.
19. Glickman, M. H., D. M. Rubin, O. Coux, I. Wefes, G. Pfeifer, Z. Cjeka, W. Baumeister, V. A. Fried, and D. Finley. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94:615-623.
20. Hahn, S. A., M. Schutte, A. T. Hoque, C. A. Moskaluk, L. T. da Costa, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
21. Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y.-Y. Xu, B. W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone, Jr., J. L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89:1165-1173.
22. Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
23. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
24. Imamura, T., M. Takase, A. Nishihara, E. Oeda, J.-I. Hanai, M. Kawabata, and K. Miyazono. 1997. Smad6 inhibits signaling by the TGF-β superfamily. Nature 389:622-626.
25. Itoh, S., M. Landstrom, A. Hermansson, F. Itoh, C.-H. Heldin, N.-E. Heldin, and P. ten Dijke. 1998. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:29195-29201.
26. Kavsak, P., R. K. Rasmussen, C. G. Caysing, S. Bonni, H. Zhu, G. H. Thomsen, and J. L. Wrana. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol. Cell 6:1365-1375.
27. Kim, S.-J., Y.-H. Im, S. D. Markowitz, and Y.-J. Bang. 2000. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev. 11:159-168.
28. Kleeff, J., T. Ishiwata, H. Maruyama, H. Friess, P. Truong, M. W. Buchler, D. Falb, and M. Korc. 1999. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18:5363-5372.
29. Kleemann, R., A. Hausser, G. Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F. J. Johannes, T. Roger, T. Calandra, A. Kapurniotu, M. Grell, D. Finkelmeier, H. Brunner, and J. Bernhagen. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216.
30. Kwok, S. F., R. Solano, T. Tsuge, D. A. Chamovitz, J. R. Ecker, M. Matsui, and X. W. Deng. 1998. Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex and their abundance is differentially affected by the pleiotropic cop/det/fus mutations. Plant Cell 10:1779-1790.
31. Lallemand, F., A. Mazars, C. Prunier, F. Bertrand, M. Kornprost, S. Gallea, S. Roman-Roman, G. Cherqui, and A. Atfi. 2001. Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells. Oncogene 20:879-884.
32. Landstrom, M., N. E. Heldin, S. Bu, A. Hermansson, S. Itoh, P. ten Dijke, and C. H. Heldin. 2000. Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells. Curr. Biol. 10:535-538.
33. Lin, X., M. Liang, and X.-H. Feng. 2000. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J. Biol. Chem. 275:36818-36822.
34. Markowitz, S. D., and A. B. Roberts. 1996. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:93-102.
35. Massagué, J., and Y. G. Chen. 2000. Controlling TGF-β signaling. Genes Dev. 14:627-644.
36. Massagué, J., and D. Wotton. 2000. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:1745-1754.
37. McManus, M. T., and P. A. Sharp. 2002. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:737-747.
38. Miyazono, K. 2000. Positive and negative regulation of TGF-β signaling. J. Cell Sci. 113:1101-1109.
39. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
40. Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.-E. Heldin, C.-H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389:631-635.
41. Okado, T., Y. Terada, H. Tanaka, S. Inoshita, A. Nakao, and S. Sasaki. 2002. Smad7 mediates transforming growth factor-β-induced apoptosis in mesangial cells. Kidney Int. 62:1178-1186.
42. Osterlund, M. T., C. S. Hardtke, N. Wei, and X. W. Deng. 2000. Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature 405:462-466.
43. Pulaski, L., M. Landstrom, C. H. Heldin, and S. Souchelnytskyi. 2001. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J. Biol. Chem. 276:14344-14349.
44. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor-βs, 419-472. In M. B. Sporn and A. B. Roberts (ed.), Peptide growth factors and their receptors, part I. Springer-Verlag, Heidelberg, Germany.
45. Schwechheimer, C., and X. W. Deng. 2000. The COP/DET/FUS proteins-regulators of eukaryotic growth and development. Semin. Cell Dev. Biol. 11:495-503.
46. Souchelnytskyi, S., T. Nakayama, A. Nakao, A. Morén, C.-H. Heldin, J. L. Christian, and P. ten Dijke. 1998. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors. J. Biol. Chem. 273:25364-25370.
47. Suzuki, C., G. Murakami, M. Fukuchi, T. Shimanuki, Y. Shikauchi, T. Imamura, and K. Miyazono. 2002. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J. Biol. Chem. 277:39919-39925.
48. Tajima, Y., K. Goto, M. Yoshida, K. Shinomiya, T. Sekimoto, Y. Yoneda, and K. Miyazono. 2003. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-β signaling by Smad7. J. Biol. Chem. 278:10716-10721.
49. Kip1 is instigated by Jab1. Nature 398:160-165.
50. Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302-2310.
51. Ulloa, L., J. Doody, and J. Massagué. 1999. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/ STAT pathway. Nature 397:710-713.
52. Wan, M., X. Cao, S. Bai, L. Wu, X. Shi, N. Wang, and X. Cao. 2002. Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep. 3:171-176.
53. Wei, N., and X. W. Deng. 1999. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet. 15:98-103.
54. Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.-F. Wang, and J. Massagué. 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014.
55. Yamamura, Y., X. Hua, S. Bergelson, and H. F. Lodish. 2000. Critical role of Smads and AP-1 complex in transforming growth factor-β-dependent apoptosis. J. Biol. Chem. 275:36295-36302.
56. Yang, H.-Y., B. P. Zhou, M.-C. Hung, and M.-H. Lee. 2000. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem. 275:24735-24739.
57. Zawel, L., J. L. Dai, P. Buckhaults, S. Zhou, K. W. Kinzler, B. Vogelstein, and S. E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611-617.
58. Zhu, H., P. Kavsak, S. Abdollah, J. L. Wrana, and G. H. Thomsen. 1999. ASMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687-693.
59. Zhu, H.-J., J. Iaria, and A. M. Sizeland. 1999. Smad7 differentially regulates transforming growth factor β-signaling pathways. J. Biol. Chem. 274:32258-32264.